CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants
The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
24 Jan 2023
Two ACP members toured Customs and Border Protection (CBP) facilities near the Texas/Mexico border to evaluate the processes and environmental conditions affecting human health at the facilities.
1 Jan 2023
National Influenza Vaccination Week 2022 is Dec. 5 to 9.
6 Dec 2022
Negative experiences for transgender patients can be avoided through gender-affirming care by physicians.
1 Jan 2023
The diagnostic approach to celiac disease in adults using serological and histologic data remains unchanged from the American College of Gastroenterology's (ACG) 2013 clinical guidelines.
17 Jan 2023
This column reviews recent recalls, alerts, and approvals.
1 Sep 2022
A 62-year-old man is evaluated for a 1-week history of burning pain and a rash over the chest and low back. Medical history is notable for idiopathic pulmonary fibrosis and a single lung transplantation 3 years ago. Following a physical exam, hospital admission, and pending test results, what is the most appropriate additional management?
10 Jan 2023
The FDA further limited use of the Johnson & Johnson (Janssen) vaccine and scheduled advisory committee meetings on other vaccine questions. Two non-mRNA vaccines showed effectiveness, and other studies looked at antibody prevalence, home test accuracy, and long-term symptoms.
10 May 2022
Misinformation and disinformation campaigns have contributed to the death toll of the COVID-19 pandemic. Internists can effectively counter this and encourage vaccinations.
1 Nov 2021
The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
19 Jul 2022